Biotechnology Stocks I Performance Guide: Madrigal Pharmaceuticals, Inc. (MDGL)
MDGL has no dividends.
Table and Chart of MDGL Performance
See what a $1,000 investment in MDGL is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| MDGL Returns | |
|---|---|
| Start Date | May-30-2014 |
| Start Price | $143.50 |
| End Date | May-10-2024 |
| End Price | $205.25 |
| # Prices | 121 |
| Min Date | Jul-29-2016 |
| Min Price | $7.50 |
| Max Date | Apr-28-2023 |
| Max Price | $312.00 |
| Total Return | 43.03% |
| Annualized Return | 3.61% |
| Current Value of $1,000 Purchase | $1,430 |
| Number Returns | 7,260 |
| Average Return | 275.72% |
| Number Profitable Returns | 4,702 |
| Percent Profitable Returns | 64.77% |
| Number Unprofitable Returns | 2,558 |
| Percent Unprofitable Returns | 35.23% |
| Profitable to Unprofitable Returns Ratio | 1.84 |
| MDGL Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $4,374,185,000 |
| Beta | -0.338 | Price to Sales |
| Earnings per Share | $-23.1300 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 12.24 |
| PRICE DATA | |
| 52 Week High | $302.68 |
| 52 Week Low | $119.76 |
| Analyst Target Price | $363.79 |
| 50-Day Moving Average | $237.87 |
| 200-Day Moving Average | $201.46 |
| FINANCIAL DATA | |
| Revenue per Share | $0 |
| Revenue | $0 |
| Profit Margin | 0% |
| Return on Equity | -88.8% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
MDGL Compare Returns with S&P 500
MDGL Trendline Chart
MDGL Moving Average Chart
MDGL Stock Return Map - See Patterns of Gains and Losses
MDGL Stock Returns/Purchase Dates